Live Breaking News & Updates on Max herrmann

Stay informed with the latest breaking news from Max herrmann on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Max herrmann and stay connected to the pulse of your community

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript

Valneva SE (NASDAQ:VALN) Q2 2023 Earnings Call Transcript September 21, 2023 Valneva SE misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.36. Operator: Good day, and thank you for standing by. Welcome to the Valneva Half Year 2023 Financial Results Call and Webcast. [Operator Instructions] Please note that today’s conference is being […]

Berlin , Germany , United-states , Japan , Bahrain , Brazil , Canada , Kingdom-of-bahrain , Japanese , Canadian , Canadians , Thomas-lingelbach

Investment in Britain has reached 'crisis' point, says Citi boss

David Livingstone raises alarm over increasing reliance on foreign investors

London , City-of , United-kingdom , Australia , Ireland , New-york , United-states , Canada , Cambridge , Cambridgeshire , Irish , Britain

Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall

Ergomed founder and executive chairman Miroslav Reljanovic's (pictured) stake in the biotech firm is currently valued at £123m.

Croatia , United-kingdom , Zagreb , Grad , London , City-of , British , Croatian , John-dawson , Sean-conroy , Max-herrmann , Danni-hewson

Private equity swoops on UK pharma firm in £703.1m deal: Ergomed founder lands £120m windfall

Ergomed founder and executive chairman Miroslav Reljanovic's (pictured) stake in the biotech firm is currently valued at £123m.

London , City-of , United-kingdom , Croatia , Zagreb , Grad , Croatian , British , Max-herrmann , John-dawson , Danni-hewson , Sean-conroy

FDA delays decision on Valneva's chikungunya vaccine

BioPharma

Denmark , Canada , France , French , Danish , Max-herrmann , Drug-administration , Pfizer , Bavarian-nordic , Pharma , Fda ,

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

Shares in UK pharmaceutical
company Hikma rose by the most in 10 months on Thursday,
hitting an 18-month high, following news of tornado damage to a
U.S. facility owned by competitor Pfizer, which...

London , City-of , United-kingdom , Rocky-mount , North-carolina , United-states , Germany , German , Max-herrmann , Jan-harvey , Amanda-cooper , Reuters

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant

Hikma, Fresenius shares rally after tornado hits rival Pfizer's U.S. plant
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Rocky-mount , North-carolina , United-states , Germany , United-kingdom , London , City-of , German , Mike-harrison , Amanda-cooper , Max-herrmann , Jan-harvey

Pfizer rivals' stocks soar after tornado destroys Rocky Mountain plant

Analysts declare Pfizer as largest supplier in US injectables market and Hikma as second-largest

United-kingdom , Rocky-mount , North-carolina , United-states , Jordan , Germany , German , Max-herrmann , Reuters , Pfizer , Fresenius , United-kingdom-based

MIDAS SHARE TIPS: Petcare firm Dechra will have its day again

Despite the cost-of-living crisis, the petcare market seems relatively robust and Dechra's pipeline is strong. Buy on this weakness.

Japan , South-korea , Max-herrmann , Andrew-whitney , Dechra-pharmaceuticals , Dailymail , Money , Moneyinvesting , Share-tips-fund , Midas-share-tips ,

MIDAS SHARE TIPS: Petcare firm Dechra will have its day again

Despite the cost-of-living crisis, the petcare market seems relatively robust and Dechra's pipeline is strong. Buy on this weakness.

Japan , South-korea , Max-herrmann , Andrew-whitney , Dechra-pharmaceuticals , Thisismoney , Money , Moneyinvesting , Share-tips-fund , Midas-share-tips ,